Ranking & Reports
When AI Meets Biotech, Geography Still Matters: Inside the France–Taiwan Debate on Drug Discovery, Capital, and Scale
2026-01-22
[Illustrations] Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect
2026-01-22
Facing a Patent Cliff, GSK Bets on a Potential Best-in-Class Food Allergy Biologic in $2.2B RAPT Deal
2026-01-20
JPM 2026 Reveals Biopharma’s High-Stakes Mix of IPO Risk, Market Turbulence, and Regulation
2026-01-19
Pfizer’s BRAFTOVI Boosts Tumor Response to 64.4% in Aggressive Colorectal Cancer Patients
2026-01-14
2026 Cardiometabolic and Weight-Loss Watchlist: Trials That Could Mint the Next Trillion-Dollar Giant
2026-01-14
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
LATEST
Trip.com Group Limited to Release Q4 and Full-Year 2025 Financial Results on February 25, 2026
2026-02-09
FireFox Gold Reports 54.91 g/t Gold Over 1.95 Meters in Northeast Zone Expansion at Mustajärvi Project
2026-02-09



